Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiopulmonary Resuscitation | 53 | 2024 | 996 | 7.130 |
Why?
|
Progeria | 23 | 2024 | 182 | 4.510 |
Why?
|
Heart Arrest | 41 | 2024 | 1516 | 4.430 |
Why?
|
Emergency Medical Services | 31 | 2024 | 1936 | 2.370 |
Why?
|
Out-of-Hospital Cardiac Arrest | 13 | 2023 | 341 | 1.920 |
Why?
|
Advanced Cardiac Life Support | 9 | 2024 | 80 | 1.630 |
Why?
|
Hospital Rapid Response Team | 3 | 2022 | 54 | 1.280 |
Why?
|
American Heart Association | 10 | 2022 | 1049 | 1.220 |
Why?
|
Consensus | 14 | 2024 | 3208 | 0.880 |
Why?
|
Epinephrine | 4 | 2021 | 782 | 0.770 |
Why?
|
Vasoconstrictor Agents | 5 | 2019 | 654 | 0.760 |
Why?
|
Patient Transfer | 4 | 2024 | 789 | 0.730 |
Why?
|
Heart Massage | 2 | 2017 | 32 | 0.710 |
Why?
|
Piperidines | 7 | 2023 | 1663 | 0.700 |
Why?
|
Intensive Care Units, Pediatric | 11 | 2023 | 1021 | 0.680 |
Why?
|
Defibrillators | 1 | 2018 | 39 | 0.600 |
Why?
|
Child | 72 | 2024 | 80668 | 0.590 |
Why?
|
Dexmedetomidine | 1 | 2022 | 321 | 0.560 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2022 | 627 | 0.550 |
Why?
|
First Aid | 8 | 2024 | 71 | 0.500 |
Why?
|
Hospitals, Pediatric | 8 | 2022 | 1851 | 0.470 |
Why?
|
Emergencies | 3 | 2015 | 1223 | 0.470 |
Why?
|
Pyridines | 6 | 2018 | 2888 | 0.470 |
Why?
|
Respiration, Artificial | 10 | 2021 | 2727 | 0.460 |
Why?
|
Transportation of Patients | 2 | 2015 | 177 | 0.430 |
Why?
|
Lamin Type A | 7 | 2023 | 186 | 0.430 |
Why?
|
Quality Indicators, Health Care | 3 | 2017 | 1804 | 0.420 |
Why?
|
Pravastatin | 3 | 2023 | 391 | 0.390 |
Why?
|
Inservice Training | 1 | 2014 | 374 | 0.390 |
Why?
|
Hypotension | 1 | 2018 | 887 | 0.390 |
Why?
|
Respiratory Insufficiency | 2 | 2010 | 1241 | 0.380 |
Why?
|
Child, Preschool | 35 | 2024 | 42577 | 0.380 |
Why?
|
Infant, Newborn | 27 | 2024 | 26389 | 0.370 |
Why?
|
Intensive Care Units | 2 | 2024 | 3799 | 0.360 |
Why?
|
Critical Care | 7 | 2024 | 2714 | 0.360 |
Why?
|
Pulmonary Surfactants | 1 | 2010 | 169 | 0.330 |
Why?
|
Cardiology | 4 | 2016 | 1701 | 0.330 |
Why?
|
Infant | 28 | 2024 | 36461 | 0.320 |
Why?
|
Emergency Treatment | 4 | 2023 | 495 | 0.320 |
Why?
|
Regional Medical Programs | 1 | 2009 | 64 | 0.320 |
Why?
|
Dystonic Disorders | 2 | 2024 | 354 | 0.320 |
Why?
|
Adolescent | 34 | 2024 | 88904 | 0.320 |
Why?
|
Humans | 112 | 2024 | 766766 | 0.300 |
Why?
|
Pediatrics | 7 | 2022 | 3614 | 0.290 |
Why?
|
Practice Guidelines as Topic | 10 | 2019 | 7431 | 0.280 |
Why?
|
Respiratory Tract Diseases | 2 | 2013 | 744 | 0.280 |
Why?
|
Catheterization, Peripheral | 1 | 2010 | 346 | 0.270 |
Why?
|
Electric Countershock | 4 | 2019 | 534 | 0.270 |
Why?
|
Decision Support Techniques | 1 | 2016 | 2006 | 0.260 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2008 | 482 | 0.240 |
Why?
|
Infant, Premature, Diseases | 1 | 2010 | 712 | 0.230 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 849 | 0.220 |
Why?
|
Retrospective Studies | 22 | 2024 | 81635 | 0.220 |
Why?
|
Critical Illness | 2 | 2022 | 2750 | 0.220 |
Why?
|
Blood Pressure | 3 | 2018 | 8533 | 0.220 |
Why?
|
Resuscitation | 4 | 2022 | 681 | 0.210 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2014 | 1481 | 0.210 |
Why?
|
Dystonia | 2 | 2024 | 378 | 0.210 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1659 | 0.200 |
Why?
|
Pharmaceutical Preparations | 2 | 2020 | 1086 | 0.200 |
Why?
|
Child, Hospitalized | 1 | 2023 | 181 | 0.190 |
Why?
|
Weaning | 1 | 2022 | 102 | 0.190 |
Why?
|
Advisory Committees | 3 | 2024 | 797 | 0.190 |
Why?
|
Age Determination by Skeleton | 2 | 2020 | 124 | 0.190 |
Why?
|
Premature Birth | 2 | 2023 | 1830 | 0.190 |
Why?
|
Health Resources | 2 | 2017 | 951 | 0.180 |
Why?
|
Cerebral Revascularization | 1 | 2023 | 260 | 0.180 |
Why?
|
Lung Diseases | 2 | 2010 | 1941 | 0.180 |
Why?
|
Diphosphonates | 2 | 2016 | 625 | 0.170 |
Why?
|
Enzyme Inhibitors | 4 | 2018 | 3721 | 0.170 |
Why?
|
Moyamoya Disease | 1 | 2023 | 274 | 0.170 |
Why?
|
Midazolam | 1 | 2021 | 267 | 0.170 |
Why?
|
Shock, Septic | 3 | 2017 | 772 | 0.170 |
Why?
|
Imidazoles | 2 | 2016 | 1168 | 0.160 |
Why?
|
Cardiopulmonary Bypass | 1 | 2024 | 1097 | 0.160 |
Why?
|
Death, Sudden, Cardiac | 2 | 2016 | 1567 | 0.150 |
Why?
|
Laryngoscopes | 1 | 2020 | 147 | 0.150 |
Why?
|
Phosphotransferases (Phosphate Group Acceptor) | 1 | 2018 | 18 | 0.150 |
Why?
|
Protein Prenylation | 2 | 2016 | 69 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5753 | 0.140 |
Why?
|
Heart Diseases | 2 | 2022 | 2817 | 0.140 |
Why?
|
Canada | 1 | 2023 | 2126 | 0.140 |
Why?
|
Teaching Rounds | 1 | 2021 | 280 | 0.140 |
Why?
|
Pulmonary Embolism | 2 | 2021 | 2596 | 0.140 |
Why?
|
Shock | 1 | 2019 | 316 | 0.140 |
Why?
|
Analgesia | 1 | 2021 | 461 | 0.140 |
Why?
|
Nursing Assessment | 1 | 2017 | 107 | 0.140 |
Why?
|
Informed Consent | 1 | 2023 | 1010 | 0.140 |
Why?
|
Hypnotics and Sedatives | 2 | 2022 | 1193 | 0.140 |
Why?
|
Bone Development | 1 | 2020 | 470 | 0.140 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15657 | 0.130 |
Why?
|
Near Drowning | 1 | 2015 | 11 | 0.130 |
Why?
|
Sexual Maturation | 1 | 2017 | 256 | 0.130 |
Why?
|
Range of Motion, Articular | 1 | 2023 | 1597 | 0.130 |
Why?
|
Emergency Medical Service Communication Systems | 1 | 2015 | 21 | 0.130 |
Why?
|
Hospital Mortality | 3 | 2019 | 5343 | 0.130 |
Why?
|
Young Adult | 11 | 2023 | 59939 | 0.130 |
Why?
|
Adult | 18 | 2023 | 223307 | 0.130 |
Why?
|
Female | 34 | 2024 | 396520 | 0.130 |
Why?
|
Walking | 1 | 2023 | 1201 | 0.120 |
Why?
|
Male | 31 | 2024 | 364142 | 0.120 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3927 | 0.120 |
Why?
|
Gingival Recession | 1 | 2018 | 210 | 0.120 |
Why?
|
Tracheotomy | 1 | 2016 | 174 | 0.120 |
Why?
|
Guidelines as Topic | 2 | 2018 | 1394 | 0.120 |
Why?
|
Deep Brain Stimulation | 1 | 2023 | 850 | 0.120 |
Why?
|
Puberty | 1 | 2017 | 495 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2019 | 754 | 0.110 |
Why?
|
Computer Simulation | 1 | 2008 | 6259 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 428 | 0.110 |
Why?
|
Clinical Competence | 3 | 2013 | 4858 | 0.110 |
Why?
|
Stroke | 3 | 2023 | 9741 | 0.110 |
Why?
|
Bone and Bones | 3 | 2016 | 2559 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2429 | 0.110 |
Why?
|
Perioperative Care | 2 | 2023 | 1043 | 0.110 |
Why?
|
Neoplasms | 3 | 2017 | 22350 | 0.110 |
Why?
|
Age Factors | 3 | 2018 | 18397 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 4 | 2018 | 2258 | 0.100 |
Why?
|
Farnesyltranstransferase | 1 | 2012 | 70 | 0.100 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2053 | 0.100 |
Why?
|
Blood Proteins | 1 | 2018 | 1194 | 0.100 |
Why?
|
Teaching | 2 | 2013 | 1171 | 0.100 |
Why?
|
Alkyl and Aryl Transferases | 2 | 2014 | 89 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1178 | 0.100 |
Why?
|
Airway Management | 1 | 2015 | 325 | 0.100 |
Why?
|
Hospitals | 2 | 2022 | 3888 | 0.100 |
Why?
|
Eye Diseases | 1 | 2017 | 660 | 0.100 |
Why?
|
ROC Curve | 2 | 2017 | 3620 | 0.090 |
Why?
|
Manikins | 1 | 2013 | 255 | 0.090 |
Why?
|
United States | 12 | 2022 | 72951 | 0.090 |
Why?
|
Health Personnel | 3 | 2021 | 3384 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1060 | 0.090 |
Why?
|
Clinical Trials as Topic | 4 | 2020 | 8045 | 0.090 |
Why?
|
Hyperventilation | 1 | 2010 | 78 | 0.090 |
Why?
|
Decision Making | 2 | 2015 | 3951 | 0.090 |
Why?
|
Protein Precursors | 1 | 2014 | 1134 | 0.080 |
Why?
|
Premedication | 1 | 2010 | 245 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2024 | 65273 | 0.080 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 574 | 0.080 |
Why?
|
Registries | 5 | 2024 | 8351 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2020 | 22248 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 41710 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1065 | 0.080 |
Why?
|
Heart | 2 | 2018 | 4425 | 0.070 |
Why?
|
Biomedical Research | 1 | 2023 | 3459 | 0.070 |
Why?
|
Algorithms | 5 | 2020 | 14072 | 0.070 |
Why?
|
Hemoglobins | 1 | 2014 | 1531 | 0.070 |
Why?
|
Recovery of Function | 1 | 2018 | 2976 | 0.070 |
Why?
|
Internship and Residency | 1 | 2008 | 5943 | 0.070 |
Why?
|
Intubation, Intratracheal | 3 | 2020 | 1359 | 0.070 |
Why?
|
Catheter-Related Infections | 1 | 2010 | 279 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14652 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 932 | 0.070 |
Why?
|
Acute Coronary Syndrome | 3 | 2015 | 2186 | 0.070 |
Why?
|
Guatemala | 2 | 2017 | 161 | 0.070 |
Why?
|
Pneumothorax | 1 | 2010 | 393 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4712 | 0.070 |
Why?
|
Risk Factors | 6 | 2021 | 74881 | 0.070 |
Why?
|
Vomiting | 2 | 2023 | 652 | 0.060 |
Why?
|
Parents | 2 | 2021 | 3593 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1364 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2228 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 538 | 0.060 |
Why?
|
Pneumonia | 1 | 2017 | 2159 | 0.060 |
Why?
|
Arsenic Poisoning | 1 | 2005 | 55 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2011 | 872 | 0.060 |
Why?
|
Echocardiography | 3 | 2018 | 5037 | 0.060 |
Why?
|
Carotid Arteries | 3 | 2016 | 932 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4765 | 0.060 |
Why?
|
Education, Continuing | 1 | 2005 | 115 | 0.060 |
Why?
|
Herbicides | 1 | 2005 | 104 | 0.060 |
Why?
|
Safety Management | 1 | 2010 | 765 | 0.060 |
Why?
|
Evidence-Based Medicine | 3 | 2010 | 3692 | 0.060 |
Why?
|
Aged | 5 | 2023 | 171343 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 987 | 0.050 |
Why?
|
Personnel, Hospital | 1 | 2005 | 285 | 0.050 |
Why?
|
Early Diagnosis | 2 | 2019 | 1186 | 0.050 |
Why?
|
Sepsis | 1 | 2017 | 2604 | 0.050 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2023 | 85 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5368 | 0.050 |
Why?
|
Acute Disease | 3 | 2021 | 7241 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15908 | 0.050 |
Why?
|
Video Recording | 2 | 2020 | 976 | 0.050 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7871 | 0.050 |
Why?
|
Observer Variation | 1 | 2008 | 2614 | 0.050 |
Why?
|
Capnography | 1 | 2002 | 90 | 0.050 |
Why?
|
Cross Infection | 1 | 2010 | 1427 | 0.050 |
Why?
|
Boston | 4 | 2017 | 9346 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12825 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9357 | 0.050 |
Why?
|
Embolectomy | 1 | 2021 | 130 | 0.040 |
Why?
|
Time Factors | 3 | 2024 | 40149 | 0.040 |
Why?
|
Nausea | 1 | 2023 | 681 | 0.040 |
Why?
|
Infant, Premature | 1 | 2010 | 2120 | 0.040 |
Why?
|
Infusions, Intraosseous | 1 | 2020 | 9 | 0.040 |
Why?
|
Atropine | 1 | 2020 | 243 | 0.040 |
Why?
|
Anthropometry | 2 | 2017 | 1336 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4499 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3618 | 0.040 |
Why?
|
Palliative Care | 1 | 2015 | 3640 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5795 | 0.040 |
Why?
|
Prospective Studies | 7 | 2023 | 54871 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 2019 | 182 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 315 | 0.040 |
Why?
|
Bone Diseases, Developmental | 1 | 2020 | 131 | 0.040 |
Why?
|
Absorptiometry, Photon | 2 | 2017 | 1707 | 0.040 |
Why?
|
Aging | 2 | 2022 | 8731 | 0.040 |
Why?
|
Heart Murmurs | 1 | 2018 | 92 | 0.040 |
Why?
|
Myoglobin | 1 | 2018 | 158 | 0.040 |
Why?
|
Interleukin-1alpha | 1 | 2018 | 88 | 0.040 |
Why?
|
Decision Trees | 1 | 2019 | 508 | 0.040 |
Why?
|
Interleukin-7 | 1 | 2018 | 146 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 1999 | 1377 | 0.040 |
Why?
|
Lidocaine | 1 | 2020 | 545 | 0.040 |
Why?
|
Eyebrows | 1 | 2017 | 38 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 330 | 0.030 |
Why?
|
Patient Discharge | 2 | 2021 | 3465 | 0.030 |
Why?
|
Pilot Projects | 2 | 2008 | 8728 | 0.030 |
Why?
|
Delphi Technique | 1 | 2020 | 892 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4780 | 0.030 |
Why?
|
Refraction, Ocular | 1 | 2017 | 188 | 0.030 |
Why?
|
Eyeglasses | 1 | 2017 | 138 | 0.030 |
Why?
|
Electric Impedance | 2 | 2010 | 791 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2019 | 414 | 0.030 |
Why?
|
Vital Signs | 1 | 2017 | 144 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2018 | 391 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6512 | 0.030 |
Why?
|
Conflict of Interest | 2 | 2010 | 556 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2418 | 0.030 |
Why?
|
Cause of Death | 2 | 2018 | 3716 | 0.030 |
Why?
|
Radiography | 2 | 2020 | 6968 | 0.030 |
Why?
|
Eyelid Diseases | 1 | 2017 | 155 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26310 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6307 | 0.030 |
Why?
|
Systems Analysis | 1 | 2015 | 168 | 0.030 |
Why?
|
Dimethylallyltranstransferase | 1 | 2014 | 8 | 0.030 |
Why?
|
Laryngoscopy | 1 | 2020 | 714 | 0.030 |
Why?
|
Checklist | 1 | 2021 | 841 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14762 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1999 | 2677 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1437 | 0.030 |
Why?
|
Middle Aged | 3 | 2023 | 223257 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2018 | 988 | 0.030 |
Why?
|
Standard of Care | 1 | 2018 | 569 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2533 | 0.030 |
Why?
|
Adenosine | 1 | 2018 | 813 | 0.030 |
Why?
|
Anesthesia | 1 | 2024 | 1595 | 0.030 |
Why?
|
Hospitalization | 3 | 2020 | 10823 | 0.030 |
Why?
|
Hospital Departments | 1 | 2013 | 134 | 0.030 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2023 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2015 | 587 | 0.020 |
Why?
|
Corneal Diseases | 1 | 2017 | 535 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 24295 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2014 | 855 | 0.020 |
Why?
|
Quality Improvement | 2 | 2017 | 3850 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 163 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 630 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2011 | 318 | 0.020 |
Why?
|
Death | 1 | 2015 | 685 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1964 | 0.020 |
Why?
|
Family | 1 | 2021 | 3209 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5618 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1596 | 0.020 |
Why?
|
Swine | 1 | 1999 | 5987 | 0.020 |
Why?
|
Growth Plate | 1 | 2011 | 275 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2011 | 357 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 843 | 0.020 |
Why?
|
Hemodynamics | 1 | 1999 | 4188 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5783 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 1733 | 0.020 |
Why?
|
Mutation | 2 | 2018 | 30213 | 0.020 |
Why?
|
Otolaryngology | 1 | 2016 | 699 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13640 | 0.020 |
Why?
|
Body Composition | 1 | 2017 | 2441 | 0.020 |
Why?
|
Myocarditis | 1 | 2015 | 802 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1794 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1374 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2011 | 577 | 0.020 |
Why?
|
Prognosis | 1 | 2008 | 29948 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2741 | 0.020 |
Why?
|
Visual Acuity | 1 | 2017 | 2714 | 0.020 |
Why?
|
Femoral Artery | 1 | 2011 | 827 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 987 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1604 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3853 | 0.020 |
Why?
|
Diarrhea | 1 | 2012 | 1317 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2171 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15416 | 0.020 |
Why?
|
Memory | 1 | 2015 | 2192 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1555 | 0.020 |
Why?
|
Myocardial Infarction | 3 | 2010 | 11513 | 0.020 |
Why?
|
Body Height | 1 | 2011 | 1562 | 0.010 |
Why?
|
Developing Countries | 1 | 2017 | 2913 | 0.010 |
Why?
|
Electrocardiography | 1 | 2018 | 6408 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4880 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3957 | 0.010 |
Why?
|
Staff Development | 1 | 2005 | 231 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7841 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6490 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2356 | 0.010 |
Why?
|
Patient Care Team | 1 | 2013 | 2519 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16724 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15831 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9602 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2005 | 1156 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1838 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1254 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10745 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 13036 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12534 | 0.010 |
Why?
|
Program Development | 1 | 2005 | 1297 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3250 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12430 | 0.010 |
Why?
|
Quality of Life | 2 | 2010 | 13476 | 0.010 |
Why?
|
Bone Density | 1 | 2011 | 3491 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2014 | 3420 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1138 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2010 | 2513 | 0.010 |
Why?
|
Public Health | 1 | 2010 | 2681 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13278 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39309 | 0.010 |
Why?
|
Heart Failure | 1 | 2018 | 11882 | 0.010 |
Why?
|
Oxygen | 1 | 2002 | 4251 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20708 | 0.000 |
Why?
|
Animals | 1 | 1999 | 168930 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20144 | 0.000 |
Why?
|